utilization reviewers scrutinize records for variations in care of patients, which may increase LOS and costs. Consequently, a particularly useful instrument would enable key early management decisions that infl uence outcomes (e.g., shorten LOS).
Th ere are many published clinical guidelines for the management of AP ( 2 ) . Implementation of guideline recommendations is variable, however, possibly because the large number of guidelines leads to uncertainty about their use ( 2 -4 ) . It is also unclear whether recommendations can be successfully implemented or that they alter outcomes. Successful introduction of management guidelines requires development, dissemination, and implementation ( 5, 6 ) . Th e latter and critical arm of this process, the design of implementation strategies, is lacking from most management guidelines for AP ( 3 ) .
Medical guideline implementation strategies include audit and audit-independent methods. Multiple retrospective and prospective audits (7 -10) , and national surveys ( 11 -13 ) have been used to identify areas of noncompliance with guideline recommendations ( 7, 8, 10 ) . Audits combined with intensive feedback modestly impact implementation of guideline recommendations in AP ( 14 ) and in other conditions ( 15 ) , but is cumbersome methodology and unlikely to alter behavior of clinicians not under scrutiny. A real-time process that interfaces with clinical decisions during the delivery of care and meets the defi nition of a clinical decision support (CDS) ( 16 ) tool may have a broader and more immediate infl uence. E.g., a CDS system that automatically prompts users about specifi c management decisions for diverse conditions (other than the exocrine pancreas) improved concordance with guideline recommendations in many but not all studies ( 17 ) .
A premise of clinical medicine is that timely implementation of best practice or guideline recommendations will improve process of care and outcomes ( 5 ) , but the impact of CDS tools on outcomes is inconsistent, understudied (17) , and unknown in AP. Outcomes in AP, however, correlate with implementing specifi c guideline recommendations, such as enteral nutrition in those with predicted moderate-severe disease or hospital stay > 7 days ( 18 ) and early endoscopic retrograde cholangiopancreatography (ERCP) ( < 72 h) in patients with cholangitis or non-resolving obstructive jaundice ( 19 ) . Strong evidence is lacking for two recommendations, including access to intensive care units ( 8, 20 ) or " aggressive " fl uid resuscitation ( 21 ) .
We hypothesized that successful implementation of The AP Early Response (TAPER)-CDS-Tool (a combined early automated paging alert system and an intuitive web-based point-ofcare instrument) would change clinician behavior, by increasing concordance with specific guideline recommen dations for AP, and shorten hospital LOS. To test our hypo theses, we collected and analyzed data for two cohorts of patients with AP who presented to the ED, one before and one immediately following the development and activation of the TAPER-CDS-Tool. We then performed univariable and multivariable analyses to determine whether the TAPER-CDS-Tool reduces hospital LOS.
Methods
In 2008, we formed a multidisciplinary team of gastroenterologists, medical and surgical ICU directors and an ED physician to discuss variances in AP management, to determine the magnitude of institutional variances and to develop and implement quality improvement measures. Th e study, entitled Th e AP Early Response (TAPER) project, was approved by the University of Michigan Institutional Review Board as two separate studies (HUM00032206 and HUM00042702) corresponding to data collection for two separate case samples (see Pre-and Post-TAPER-CDS-Tool Case Samples). Based on a preliminary audit and consensus agreement about key guideline recommendations, we developed the TAPER-CDS-Tool (12 / 2008 to 05 / 2010), consisting of a combined early automated paging-alert system and intuitive web-based point-of-care instrument, which provides clinicians information for making key decisions when patients with AP present to the ED.
Selection of pre-and post-TAPER-CDS-tool case samples
Following development of the TAPER-CDS-Tool (see below), we conducted two separate IDX cross-sectional searches of our health system ' s databases ( 
Patient identifi cation .
Th e study team searched the electronic health record of patients with the ICD-9 code 577.0 generated from ED or hospital units to confi rm the diagnosis of AP based on having two of three a priori criteria ( ≥ 3-fold increase in serum amylase or lipase, abdominal pain, and typical imaging evidence of acute pancreatitis) (22) , and that these patients presented to the ED during the periods of the study and had no exclusion criteria (see Figure 1 ). Specifi cally excluded were patients with the diagnosis of chronic pancreatitis made by a clinical scoring system ( 23 ) that included imaging (calcifi cation, Cambridge II, > 5 abnormal EUS features) and / or abnormal function.
Variables and defi nitions . All study variables are defi ned in Supplementary Table 1 online.
Th e early automated paging alert system component of the TAPER-CDS-tool . ED clinicians were alerted by the automated paging alert system of the TAPER-CDS-Tool ( Figure 2 ) when hyperamylasemia or hyperlipasemia ( > threefold normal) was present in the electronic records of ED patients. Th e alert system pages the clinician by a text message about a possible diagnosis of AP and directs the clinician to the intuitive web-based point-ofcare instrument named " PancMap " . Table 1 ), formulated by consensus agreement among multidisciplinary faculty aft er discussing evidence from reviews ( 24 -29 ) and clinical guidelines ( 20, 30 ) . Th ese include diagnosis in the ED; assignment of etiology; early ERCP ( < 72 h) for cholangitis or non-resolving obstructive jaundice; risk stratifi cation in the ED (by any means but with emphasis on assessment of transient organ failure ( 30, 31 ) and the clinical scoring systems SIRS criteria ≥ 2 ( 32 ) and BISAP score ≥ 3 ( 33 )); triage to ICU for severe AP; intravenous (IV) fl uid therapy (FT) > 250 cc / h ( > 6L / 24 h) using a resuscitation algorithm, and enteral feeding for predicted severe AP or prolonged hospital LOS.
To achieve the FT goal advocated by expert reviews ( 24 -28 ) and a practice guideline ( 30 ), we developed an intuitive algorithm ( Figure 2 , bottom) modeled aft er goal-directed FT in sepsis / shock ( 34, 35 ) , and investigational protocols in AP ( 36 ) that mirror the structure of recently published protocols ( 37, 38 ) . Th e algorithm includes cautious FT in AP patients with preexisting organ failure, crystalloid boluses to achieve hemodynamic stability ( 26, 34 ) , and an initial FT maintenance rate of > 221 ml / h or > 3 cc / 70 kg / h that Wall et al. ( 39 ) reported in 2009 (in abstract form) that improves survival ( 39 ) . Further FT boluses ( 34 ) and maintenance rate adjustments are based on hemodynamic stability and serial measures of blood urea nitrogen (BUN) , a prognostic variable ( 33,40 -43 ) and surrogate marker of adequate FT.
Data collection .
Coinvestigators JPS, SG, TS, JC, MJD and EJW used methods identical to our previous studies ( 44 ) to use the search engine EMERSE ( 44 ) to examine the electronic health record for data of interest, to reconcile variations in the data recorded in the electronic health record, and to collect and tabulate data with Microsoft Excel (Microsoft , Redmond, WA) spreadsheets for data management. Data from nursing fl ow sheets were reviewed manually if vital signs and fl uid volumes were not available electronically. To calculate values for clinical scoring systems (see Table 1 ), we used the most abnormal values during the fi rst 0 -24 h of presentation ( 45 ) and added no points for missing data ( 33, 45 ) .
Study outcomes .
Th e primary outcome of the study was hospital LOS among patients alive at hospital discharge. In 39 patients awaiting cholecystectomy for gallstone AP, the LOS we used for study purposes was shortened to the preoperative day when the patient met three discharge criteria of minimal or no abdominal pain, a normal amylase and lipase or values less than threefold elevated and tolerating a soft or solid diet. Th e median shortening of LOS in days (interquartile range) by this method for patients undergoing cholecystectomy was not signifi cantly diff erent between the pre-and post-TAPER-CDS-Tool groups (2 (0 -3) vs. 2 (1 -5.75), P = 0.3704).
Statistical analyses . Descriptive statistics were compiled on all variables to evaluate distributions prior to modeling. Categorical and dichotomous variables were assessed by χ 2 -tests or Fisher ' s exact test when necessary. Continuous variables were assessed using two sample t -tests for normally distributed variables and the Wilcoxon rank-sum test for non-parametric continuous data ( Tables 1 and 2 ). To model hospital LOS as a continuous dependent variable ( Table 3 ) , data for LOS (days) were transformed to a coeffi cient of determination (r 2 ) by one-way analysis of variance for dichotomous variables and by bivariate simple linear regression for continuous variables ( ( 46 ) selected on the basis of having the lowest corrected Akaike ' s information criterion out of 11 transformation options (e.g., log normal, G log, etc.)). We performed univariable analysis for the association of each variable with LOS by determining the signifi cance of its Th e model was used to estimate the odds ratio and associated 95 % confi dence intervals. Statistical signifi cance was defi ned as P < 0.05. Statistical analyses were performed using JMP version Pro 10 (SAS Institute, Cary, NC).
Sample size calculations . Th e study was designed to investigate whether the TAPER-CDS-Tool, the study " intervention " independently infl uenced LOS (a continuous variable). Based on mean (s.d.) LOS calculated for the pre-TAPER-CDS-Tool group of 108 consecutive patients with AP alive at discharge ( Table 2B ) , we projected that a sample size of 99 per group had an 80 % power (alpha level < 0.05) to detect a hypothesized clinically important diff erence of 2 days in LOS between the pre-and post-TAPER-CDS-Tool groups. We accrued consecutive AP patients in the post-TAPER-CDS-Tool group to match the pre-TAPER-CDSTool sample size.
Results
Characteristics of study subjects . Th e pre-and post-TAPER-CDS-Tool groups were similar ( ( 47 ) .
Eff ect of TAPER-CDS-tool on compliance with management goals .
Two of the seven recommended early management goals for AP ( Table 2A ) Eff ect of TAPER-CDS-tool on outcomes . Hospital LOS was signifi cantly shorter in the post-vs. pre-TAPER-CDS-Tool groups ( Table 2B ) . Th e overall mean (s.d.) LOS was 4.6 (3.1) vs. 6.7 (7.0) days, P = 0.0126. In mild AP, LOS was 4.0 (2.5) vs. 4.9 (3.0) days, P = 0.0113 and in moderate-severe AP, LOS was 7.0 (3.9) vs. 14.5 (12.4) days, P = 0.0383. Th e overall median assigned an etiology of AP (72 % ) and performed early ERCP ( < 72 h) for cholangitis and non-resolving biliary obstruction (100 % ) but infrequently admitted patients from the ED to the ICU (1.8 % overall and 6.2 % with moderate-severe AP) or provided enteral nutrition (3.1 % overall and 10.4 % with moderate-severe AP). , coeffi cient of determination; TAPER, The Acute Pancreatitis Early Response. Statistics: Multivariable analysis was by standard least squares regression and included variables from the univariable analysis with P < 0.2. a Two of seven early management variables were excluded from multivariable analysis: admission from the ED to the ICU was excluded because of insuffi cient numbers ( N =4) and early ERCP < 72 h because all patients in both groups with cholangitis or non-resolving biliary obstruction had ERCP < 72 h. b The Japanese severity score ( 42 ) was selected to represent six clinical scoring systems (defi ned in Supplementary Table 1 ) on the basis of a recent multicenter study ( 45 ) for predicting severe AP and performance characteristics for predicting both moderate-severe AP and LOS in our data set ( Supplementary Table 2 ). To calculate values for clinical scoring systems, we analyzed the most abnormal values during the fi rst 0 -24 h of presentation ( 45 ) and added no points for missing data ( 33, 45 ) .
(interquartile range) LOS was 4 (3 -6) vs. 4.5 (3 -8) days, P = 0.0126. In mild AP, median (interquartile range) LOS was 3 (2 -4) vs. 4 (3 -6) days, P = 0.0113 and in moderate-severe AP, LOS was 6 (5 -8.5) vs. 11.5 (5 -19.5) days, P = 0.0383.
With univariable analysis, 11 variables associated with LOS ( P < 0.05; Table 3 , left panel). Th e TAPER-CDS-Tool associated with shorter LOS and 10 variables associated with longer LOS. In multivariable standard least squares regression analysis, four independent variables out of 14 included in the model (based on having a P -value < 0.2 in the univariable analysis) were associated with LOS ( Table 3 , right panel). Th e TAPER-CDSTool was associated with shorter LOS and three variables were associated with longer LOS: greater Japanese severity score, persistent organ failure and local pancreatic complications. Two of seven early management variables were excluded from multivariable analysis: admission from the ED to the ICU was excluded because of insuffi cient numbers ( N = 4 patients) and early ERCP < 72 h because all patients in both groups with cholangitis or non-resolving biliary obstruction ( Table 2A ) had ERCP < 72 h.
Discussion
Th e main fi nding of this study was that the TAPER-CDS-Tool, the combined early automated paging alert system, and intuitive web-based point-of-care instrument, was associated with significantly shorter hospital LOS. Th e overall mean reduction of LOS was 2.1 days, 0.9 days for mild AP, and 7.5 days for moderate to severe AP, resulting in an overall reduction of 226.8 days LOS for the entire post-TAPER-CDS-Tool group of patients discharged from the hospital alive. Based on aggregate hospitalization costs of $ 1,845 / day for AP from the 2009 Nationwide Inpatient Sample ( 1 ), we estimate that implementation of the TAPER-CDS-Tool would reduce our annual institutional costs by 0.4 million dollars and annual costs in the United States by 1.06 billion dollars for 274,119 AP hospital discharges.
Th e second major fi nding was that the TAPER-CDS-Tool induced the clinicians to alter management of AP by increasing execution of two of seven recommended early management goals; risk stratifying patients in the ED and administering IV FT > 6 L within 0 -24 h of presentation. Th ese data corroborate observations from audits ( 7 -10 ) and national surveys ( 11 -13 ) . In these reports, the guideline recommendations for managing AP that were variably implemented included early risk stratifi cation ( 8 ) , enteral feeding for patients with severe AP ( 13 ) , and treating gallstones during the same hospital stay or at least within 2 -4 weeks aft er onset of disease to avoid high readmission rates ( 7, 9 ) .
Compliance with clinical guidelines varies by level of expertise ( 11 ) but noncompliance may occur when recommendations are general, lack evidence and require resources that are not controlled or available to the practitioner (access to endoscopy, surgery, and ICU) ( 12 ) . The intuitive design and immediate availability of the TAPER-CDS-Tool aided in realtime decisions made by clinicians actively managing AP and increased compliance of two of the seven-guideline recommendations.
No single guideline recommended goal, however, including the increased frequency of risk stratifying and administering IV FT > 6 L within the fi rst 0 -24 h, was signifi cantly associated with LOS. Th is fi nding is consistent with observations that more frequent risk stratifi cation does not directly aff ect outcomes ( 8 ) and " aggressive " FT has a postulated but unproven impact on outcomes ( 21 ) . Because the defi nition and impact of " aggressive " FT are uncertain, we emphasize that persistent organ failure was not signifi cantly greater in patients with predicted mild AP (based on Japanese severity score < 3) who received FT > 6 L vs. ≤ 6 L within the fi rst 0 -24 h (0 / 19 (0 % ) vs. 8 / 170 (4.7 % ) P = 1.000; data not shown). It is noteworthy that compliance aft er implementation of the TAPER-CDS-Tool for these recommendations was only 28.3 % for risk stratifi cation and 20 % for administering IV FT > 6 L during the fi rst 24 h. In contrast to compliance with individual guideline recommendations, execution of all of the top fi ve most frequently implemented guideline recommendations (establishing an early diagnosis of AP, assigning an etiology of AP, performing early ERCP ( < 72 h) for cholangitis and non-resolving biliary obstruction, risk stratifying patients in the ED and administering IV FT > 6 L within 0 -24 h of presentation) was low in the pre-and post-TAPER-CDS-Tool groups (0.0 and 8.0 % (9 of 113); data not shown).
Th ree guideline recommendations that may improve outcomes in AP had a similar high or low frequency of implementation in the pre-and post-TAPER-CDS-Tool periods: access to an ICU ( 8, 20 ) (rarely used), enteral nutrition ( 18 ) (rarely used) and early ERCP ( < 72 h) ( 19 ) (always used). Th e infrequent use of ICU is explained by limited availability and high resource utilization ( 20 ) in a congested referral center hospital. Infrequent use of enteral nutrition is likely due to the combination of insuffi cient emphasis in the TAPER-CDS-Tool and not independently focusing on the interface with hospital providers (rather than ED clinicians) who are responsible for decisions regarding enteral feeding. Greater emphasis on enteral nutrition is required for future quality improvement eff orts, but decisions to initiate certain treatments such as enteral nutrition rely on estimating LOS and severity.
Besides promoting increased implementation of some management guideline recommendations and an association with reduced LOS, we propose that the TAPER-CDS-Tool may also have less tangible but important eff ects such as fostering effi cient and attentive care, and increasing unanimity among multidisciplinary teams. We cannot exclude that the decrease in hospital LOS in the post-vs. pre-TAPER-CDS-Tool time periods is due to a decline in LOS for AP in the United States, as between the years 1997 -2003 ( 48 ), but we believe this is an unlikely explanation. Most importantly, serial data from the Nationwide Inpatient Sample indicates that median hospital LOS was stable (4.0) between the years 2000 -2009 ( 1, 49, 50 ) , which matches the overall median (interquartile range) LOS for AP in the pre-TAPER-CDS-Tool group (spanning 5 / 30 / 06 -6 / 22 / 2007) and indicates that LOS for AP may have plateaued over the duration of this study. To extend the observations of the study and address the limitations of the observational study design, we plan to use the accrued pilot data to design a multicenter cluster randomized trial.
Automating prediction of LOS and severity of AP might facilitate key early management decisions that infl uence outcomes. Major determinants of LOS are known, such as persistent organ failure ( 32 ) . However, the best predictor of LOS is unknown among scoring systems (Ranson and APACHE II), artifi cial neural network simulation and linear discrimination analysis ( 51, 52 ) . In a recent report ( 45 ) , however, the Japanese severity score ( 42 ) had good and superior performance characteristics compared with other clinical scoring systems for predicting severe AP on admission and at the 48 h. Similarly, we found by post hoc analyses that the Japanese severity score has a numerically greater correlation and predictive value, respectively, for hospital LOS and moderate-severe AP ( Supplementary Table 2 ). In addition, four commonly available and independent variables might predict LOS and moderate-severe AP as well as six clinical scoring systems. Th e variables for LOS are temperature ( ° C), bicarbonate, white blood cell count, and Glasgow coma score, and for moderate-severe AP are heart rate, bicarbonate, white blood cell count, and creatinine ( Supplementary Table 3 ). Th ese data provide a rationale for automating the prediction of moderate-severe AP and LOS by using a few commonly available variables in the electronic medical record and a simple clinical scoring system (Glasgow coma scale). Communicating these predictions to clinicians through a modifi ed TAPER-CDS-Tool might enable key early management decisions, including IV fl uids, ICU care, and enteral nutrition and further reduce LOS.
In summary, we demonstrate the successful implementation of an automated TAPER-CDS-Tool, consisting of a combined early automated paging alert system and an intuitive web-based point-of-care instrument, for application of AP clinical guidelines. Th e TAPER-CDS-Tool associated with changes in clinician behavior (reducing variations in recommended practice) and shortened hospital LOS, which has signifi cant fi nancial implications. Despite these changes associated with the TAPER-CDS-Tool, overall compliance with guideline recommendations for AP was low. It should be possible, however, with additional quality improvement eff orts, to increase compliance for several recommendations that may signifi cantly shorten LOS, particularly risk stratifi cation and enteral nutrition. Eventually, prospective randomized studies will be required to validate our fi ndings and to determine whether the TAPER-CDSTool compared with improvements of the TAPER-CDS-Tool (automation of risk stratifi cation, greater emphasis on using enteral nutrition) infl uence clinician behavior and shorten hospital LOS.
